Assessing appropriateness of lipid management among patients with diabetes mellitus moving from target to treatment

Medicine and Dentistry

• Adverse Event 10%
• Age 50%
• Combination Therapy 10%
• Diabetes Mellitus 40%
• Drug Megadose 20%
• Dyslipidemia 10%
• Health Care Cost 10%
• Inpatient 20%
• Ischemic Heart Disease 10%
• Lipid 20%
• Low-Density Lipoprotein 70%
• Measurement 10%
• Mental Capacity 10%
• Patient 100%
• Patient with Diabetes 60%
• Pimeprofen 10%
• Therapeutic Procedure 20%
• Veteran 20%
• Veterans Affairs 10%

Nursing and Health Professions

• Adverse Event 10%
• Combination Therapy 10%
• Diabetes Mellitus 40%
• Dose 30%
• Drug Megadose 20%
• Dyslipidemia 10%
• Electric Potential 10%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 30%
• Ischemic Heart Disease 10%
• Lipid 20%
• Low Density Lipoprotein 70%
• Measurement 10%
• Overtreated 20%
• Pimeprofen 10%
• Primary Medical Care 10%
• Procedures 10%
• Statin (Protein) 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 10%
• Diabetes Mellitus 40%
• Dyslipidemia 10%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 30%
• Ischemic Heart Disease 10%
• Lipid 20%
• Low Density Lipoprotein 70%
• Pimeprofen 10%
• Statin (Protein) 50%